# A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739

> **NCT03437590** · PHASE1 · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 13 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-55308942
- **DRUG:** [18F]-JNJ-64413739

## Key facts

- **NCT ID:** NCT03437590
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-15
- **Primary completion:** 2018-10-19
- **Final completion:** 2018-10-19
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437590, "A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03437590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*